Your browser doesn't support javascript.
COVID-19 Vaccination Uptake Among a Nationwide Sample of People Living With HIV During the Early Phase of Vaccine Rollout in China.
Yang, Jianzhou; Yu, Maohe; Fu, Gengfeng; Lan, Guanghua; Li, Linghua; Qiao, Ying; Zhao, Jin; Qian, Han-Zhu; Zhang, Xiangjun; Liu, Xinchao; Jin, Xia; Chen, Guohong; Fang, Yuan; Wang, Zixin; Xu, Junjie.
  • Yang J; Department of Preventive Medicine, Changzhi Medical College, Changzhi, China.
  • Yu M; Tianjin Center for Disease Control and Prevention, Tianjin, China.
  • Fu G; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
  • Lan G; Guangxi Center for Disease Control and Prevention, Nanning, China.
  • Li L; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
  • Qiao Y; The Second Hospital of Huhhot, Huhhot, China.
  • Zhao J; Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
  • Qian HZ; SJTU-Yale Joint Center for Biostatistics and Data Sciences, Shanghai Jiao Tong University, Shanghai, China.
  • Zhang X; Department of Public Health, University of Tennessee, Knoxville, TN, United States.
  • Liu X; Peking Union Medical College Hospital, Beijing, China.
  • Jin X; AIDS Healthcare Foundation (AHF) China, Beijing, China.
  • Chen G; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
  • Fang Y; Department of Health and Physical Education, The Education University of Hong Kong, Hong Kong, China.
  • Wang Z; JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Xu J; Clinical Research Academy, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.
Front Med (Lausanne) ; 9: 822680, 2022.
Article in English | MEDLINE | ID: covidwho-2109779
ABSTRACT
People living with HIV (PLWH), if infected with Coronavirus Disease 2019 (COVID-19), had an increased risk of mortality compared to people without HIV infection. They are considered as a priority group to receive COVID-19 vaccination. This cross-sectional online survey investigated the prevalence of and factors associated with COVID-19 vaccination uptake among 2740 PLWH aged 18-65 years in eight Chinese metropolitan cities between January and February 2021. As validated by requesting participants to send an image of receipt hiding personal identification, 6.2% of PLWH had taken up COVID-19 vaccination. Participants living in cities where individuals could make an appointment to receive COVID-19 vaccination reported significantly higher uptake than those living in cities without such allowance (11.0 vs. 2.9%, p < 0.001). Being a member of priority groups to receive vaccination, concerning about the side effects of COVID-19 vaccination and its interaction with HIV treatment, and exposing to information on the Internet/social media supporting PLWH to receive COVID-19 vaccination were significantly associated with COVID-19 vaccination uptake in both groups of participants. Receiving advice from the staff of community-based organizations supporting COVID-19 vaccination was associated with higher uptake among participants living in cities where individuals could make an appointment to receive such vaccination, while a shortage in COVID-19 vaccine supply was associated with a lower uptake among participants living in other cities. Our findings presented a snapshot of COVID-19 vaccination uptake among PLWH in the early phase of vaccine rollout in China. It provided a knowledge basis to formulate interventions promoting COVID-19 vaccination for PLWH.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Language: English Journal: Front Med (Lausanne) Year: 2022 Document Type: Article Affiliation country: Fmed.2022.822680

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Language: English Journal: Front Med (Lausanne) Year: 2022 Document Type: Article Affiliation country: Fmed.2022.822680